AU2019363806B2 - Chromosome biomarker - Google Patents
Chromosome biomarker Download PDFInfo
- Publication number
- AU2019363806B2 AU2019363806B2 AU2019363806A AU2019363806A AU2019363806B2 AU 2019363806 B2 AU2019363806 B2 AU 2019363806B2 AU 2019363806 A AU2019363806 A AU 2019363806A AU 2019363806 A AU2019363806 A AU 2019363806A AU 2019363806 B2 AU2019363806 B2 AU 2019363806B2
- Authority
- AU
- Australia
- Prior art keywords
- obd142
- chromosome
- obd154
- interactions
- signaling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1817181.9A GB201817181D0 (en) | 2018-10-22 | 2018-10-22 | Chromosome biomarker |
| GB1817181.9 | 2018-10-22 | ||
| GBGB1904066.6A GB201904066D0 (en) | 2019-03-25 | 2019-03-25 | Chromosome biomarker |
| GB1904066.6 | 2019-03-25 | ||
| PCT/GB2019/052996 WO2020084289A1 (en) | 2018-10-22 | 2019-10-21 | Chromosome biomarker |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019363806A1 AU2019363806A1 (en) | 2021-05-06 |
| AU2019363806B2 true AU2019363806B2 (en) | 2022-03-31 |
Family
ID=68296533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019363806A Active AU2019363806B2 (en) | 2018-10-22 | 2019-10-21 | Chromosome biomarker |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12584172B2 (https=) |
| EP (1) | EP3870719A1 (https=) |
| JP (1) | JP7599417B2 (https=) |
| KR (1) | KR102901797B1 (https=) |
| CN (1) | CN113366121A (https=) |
| AU (1) | AU2019363806B2 (https=) |
| CA (1) | CA3115024A1 (https=) |
| IL (1) | IL282089B2 (https=) |
| MY (1) | MY204616A (https=) |
| SG (1) | SG11202103603VA (https=) |
| TW (1) | TWI861021B (https=) |
| WO (1) | WO2020084289A1 (https=) |
| ZA (1) | ZA202102664B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220170766A (ko) | 2021-06-22 | 2022-12-30 | 주식회사 엘지화학 | 단백질 키나아제 억제제로서의 신규한 화합물 |
| GB202412610D0 (en) * | 2024-08-28 | 2024-10-09 | Oxford BioDynamics PLC | Screening method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7998744B2 (en) | 2008-07-28 | 2011-08-16 | Greenwood Genetic Center, Inc. | Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders |
| WO2012106559A1 (en) | 2011-02-02 | 2012-08-09 | Translational Genomics Research Institute | Biomarkers and methods of use thereof |
| US9284594B2 (en) | 2013-07-23 | 2016-03-15 | The Regents Of The University Of Michigan | Compositions and methods relating to fusion protein biomarkers |
| JP2018527016A (ja) * | 2015-06-24 | 2018-09-20 | オックスフォード バイオダイナミックス リミテッド | 染色体相互作用の検出 |
| CN108359732A (zh) * | 2017-01-25 | 2018-08-03 | 株式会社大熊制药 | 用于预测训练反应的生物标志物 |
-
2019
- 2019-10-21 EP EP19790766.0A patent/EP3870719A1/en active Pending
- 2019-10-21 WO PCT/GB2019/052996 patent/WO2020084289A1/en not_active Ceased
- 2019-10-21 KR KR1020217015713A patent/KR102901797B1/ko active Active
- 2019-10-21 CN CN201980085359.4A patent/CN113366121A/zh active Pending
- 2019-10-21 SG SG11202103603VA patent/SG11202103603VA/en unknown
- 2019-10-21 CA CA3115024A patent/CA3115024A1/en active Pending
- 2019-10-21 JP JP2021523241A patent/JP7599417B2/ja active Active
- 2019-10-21 MY MYPI2021001896A patent/MY204616A/en unknown
- 2019-10-21 US US17/287,092 patent/US12584172B2/en active Active
- 2019-10-21 IL IL282089A patent/IL282089B2/en unknown
- 2019-10-21 AU AU2019363806A patent/AU2019363806B2/en active Active
- 2019-10-22 TW TW108138132A patent/TWI861021B/zh active
-
2021
- 2021-04-21 ZA ZA2021/02664A patent/ZA202102664B/en unknown
Non-Patent Citations (1)
| Title |
|---|
| Bouchard, C., ‘Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study'. Journal of Applied Physiology. February 2000, vol.88, pages 551-559 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI861021B (zh) | 2024-11-11 |
| IL282089A (en) | 2021-05-31 |
| WO2020084289A1 (en) | 2020-04-30 |
| AU2019363806A1 (en) | 2021-05-06 |
| KR102901797B1 (ko) | 2025-12-17 |
| IL282089B2 (en) | 2024-08-01 |
| SG11202103603VA (en) | 2021-05-28 |
| CN113366121A (zh) | 2021-09-07 |
| KR20210080516A (ko) | 2021-06-30 |
| US20220282328A1 (en) | 2022-09-08 |
| ZA202102664B (en) | 2022-10-26 |
| CA3115024A1 (en) | 2020-04-30 |
| IL282089B1 (en) | 2024-04-01 |
| JP2022512842A (ja) | 2022-02-07 |
| JP7599417B2 (ja) | 2024-12-13 |
| EP3870719A1 (en) | 2021-09-01 |
| NZ775029A (en) | 2025-03-28 |
| MY204616A (en) | 2024-09-05 |
| US12584172B2 (en) | 2026-03-24 |
| TW202035704A (zh) | 2020-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer | |
| Ordulu et al. | Structural chromosomal rearrangements require nucleotide-level resolution: lessons from next-generation sequencing in prenatal diagnosis | |
| Paul et al. | Transcriptional architecture of synaptic communication delineates GABAergic neuron identity | |
| Trimarchi et al. | Molecular heterogeneity of developing retinal ganglion and amacrine cells revealed through single cell gene expression profiling | |
| Chan et al. | Assessment of myometrial transcriptome changes associated with spontaneous human labour by high‐throughput RNA‐seq | |
| US10851415B2 (en) | Molecular predictors of sepsis | |
| CN114875118B (zh) | 确定细胞谱系的方法、试剂盒和装置 | |
| Zhu et al. | Identification of micro‐RNA networks in end‐stage heart failure because of dilated cardiomyopathy | |
| US11840737B2 (en) | Genetic regulation of immunoresponse by chromosome interactions | |
| Palmieri et al. | Genome-wide pathway analysis using gene expression data of colonic mucosa in patients with inflammatory bowel disease | |
| WO2019135957A1 (en) | Immune gene expression signature in treg enriched tumor samples | |
| AU2019363806B2 (en) | Chromosome biomarker | |
| Fornari et al. | Comprehensive survey of miRNA-mRNA interactions reveals that Ccr7 and Cd247 (CD3 zeta) are posttranscriptionally controlled in pancreas infiltrating T lymphocytes of non-obese diabetic (NOD) mice | |
| Zhang et al. | A cell atlas of chromatin accessibility across 25 adult human tissues | |
| US20180046754A1 (en) | Normalization methods for measuring gene copy number and expression | |
| US11535893B2 (en) | Typing method | |
| WO2017221040A2 (en) | Genetic diagnostics of intellectual disability disorder, autism spectrum disorder and epilepsy | |
| AU2022230780B2 (en) | Chromosome interaction markers | |
| TWI884984B (zh) | 診斷染色體標記 | |
| JP2023545097A5 (https=) | ||
| Hagler et al. | Unraveling the molecular complexity of myxomatous mitral valve degeneration: integrating transcriptomic and miRNA profiling using random forests with Boruta feature selection | |
| US20240392363A1 (en) | Methods for discriminating between fetal and maternal events in non-invasive prenatal test samples | |
| Suh et al. | The regulatory landscapes of human ovarian ageing | |
| Paterson | The Hunt for Novel Prognostic Blood Biomarkers of Hypertension | |
| Rabinowitz et al. | High rate of microdeletions in miscarriage products of conception (POC) samples suggests role for preimplantation genetic diagnosis (PGD) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |